Back to Superinvestors
SUPERINVESTOR HOLDERS

DNLI

Denali Therapeutics Inc
—
Holders
1
Total value
$9,991,416
Total shares
388,469
Cross-link
Financials →
Investor Shares Value % of Portfolio Activity As of
Cliff Asness
AQR Capital Management
388,469 $9,991,416 0.00% ADD +285,890 30 Jun 2026